Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Table 1 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Modeling the Effects of Multiple Myeloma on Kidney Function | Scientific Reports
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Table 5 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar